Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Onychomycosis: a review.
Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, Piraccini BM. Gupta AK, et al. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1972-1990. doi: 10.1111/jdv.16394. Epub 2020 Jun 5. J Eur Acad Dermatol Venereol. 2020. PMID: 32239567 Review.
Terbinafine, itraconazole and fluconazole are most commonly used, with new oral antifungals such as fosravuconazole being evaluated. Topical treatments, such as efinaconazole, tavaborole, ciclopirox and amorolfine have less serious side effects, but also have generally low …
Terbinafine, itraconazole and fluconazole are most commonly used, with new oral antifungals such as fosravuconazole being evaluated. …
Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.
Gupta AK, Talukder M, Venkataraman M. Gupta AK, et al. Int J Dermatol. 2022 Dec;61(12):1431-1441. doi: 10.1111/ijd.15999. Epub 2021 Dec 9. Int J Dermatol. 2022. PMID: 34882787 Review.
We have summarized the most appropriate dosing regimens of posaconazole, fosravuconazole, voriconazole, and oteseconazole (VT-1161) to treat onychomycosis and superficial fungal infections. ...The efficacies (complete cure and mycologic cure) of the antifungal agents for d …
We have summarized the most appropriate dosing regimens of posaconazole, fosravuconazole, voriconazole, and oteseconazole (VT-1161) t …
Dermatophytomas: Clinical Overview and Treatment.
Gupta AK, Wang T, Cooper EA. Gupta AK, et al. J Fungi (Basel). 2022 Jul 19;8(7):742. doi: 10.3390/jof8070742. J Fungi (Basel). 2022. PMID: 35887497 Free PMC article. Review.
Current data indicates these topicals may provide efficacy for dermatophytoma treatment without debridement/avulsion. Similarly, fosravuconazole (F-RVCZ) has an improved pharmacological profile versus ravuconazole and may be an improved treatment option versus traditional …
Current data indicates these topicals may provide efficacy for dermatophytoma treatment without debridement/avulsion. Similarly, fosravuc …
Transplantation for chagas' disease: closing the knowledge gap.
La Hoz RM. La Hoz RM. Curr Opin Infect Dis. 2022 Oct 1;35(5):397-403. doi: 10.1097/QCO.0000000000000868. Epub 2022 Aug 3. Curr Opin Infect Dis. 2022. PMID: 35942849 Review.
Benznidazole or nifurtimox can be used for treatment. Posaconazole and fosravuconazole did not provide any additional benefit compared to benznidazole alone or in combination. ...
Benznidazole or nifurtimox can be used for treatment. Posaconazole and fosravuconazole did not provide any additional benefit compare …
Review on Experimental Treatment Strategies Against Trypanosoma cruzi.
Mazzeti AL, Capelari-Oliveira P, Bahia MT, Mosqueira VCF. Mazzeti AL, et al. J Exp Pharmacol. 2021 Mar 31;13:409-432. doi: 10.2147/JEP.S267378. eCollection 2021. J Exp Pharmacol. 2021. PMID: 33833592 Free PMC article. Review.
The CYP51 antifungal azoles, as posaconazole, ravuconazole and its prodrug fosravuconazole presented promising results in experimental Chagas disease. ...
The CYP51 antifungal azoles, as posaconazole, ravuconazole and its prodrug fosravuconazole presented promising results in experimenta …
Monotherapy and combination chemotherapy for Chagas disease treatment: a systematic review of clinical efficacy and safety based on randomized controlled trials.
Santana Nogueira S, Cardoso Santos E, Oliveira Silva R, Vilela Gonçalves R, Lima GDA, Dias Novaes R. Santana Nogueira S, et al. Parasitology. 2022 Nov;149(13):1679-1694. doi: 10.1017/S0031182022001081. Epub 2022 Aug 12. Parasitology. 2022. PMID: 35957576 Free PMC article. Review.
ChD diagnosis was mainly based on haemagglutination, immunofluorescence, enzyme-linked immunosorbent assay and polymerase chain reaction. Benznidazole (BNZ), nifurtimox, fosravuconazole, posaconazole, allopurinol and thioctic acid were the identified drugs. ...Therefore, s …
ChD diagnosis was mainly based on haemagglutination, immunofluorescence, enzyme-linked immunosorbent assay and polymerase chain reaction. Be …
The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration.
Pfarr KM, Krome AK, Al-Obaidi I, Batchelor H, Vaillant M, Hoerauf A, Opoku NO, Kuesel AC. Pfarr KM, et al. Parasit Vectors. 2023 Mar 1;16(1):82. doi: 10.1186/s13071-022-05581-4. Parasit Vectors. 2023. PMID: 36859332 Free PMC article. Review.
Phase 2 studies of emodepside and flubentylosin in O. volvulus-infected individuals are ongoing; studies for Trichuris trichuria and hookworm are planned. A trial of fosravuconazole in Madurella mycetomatis-infected patients is ongoing. ...
Phase 2 studies of emodepside and flubentylosin in O. volvulus-infected individuals are ongoing; studies for Trichuris trichuria and hookwor …